ORADUR-based Opioids #2
/ Filana Therapeutics, Pfizer
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 15, 2021
Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
(clinicaltrials.gov)
- P3; N=64; Completed; Sponsor: Orient Pharma Co., Ltd.; Recruiting ➔ Completed
Clinical • Trial completion • ADHD (Impulsive Aggression) • Attention Deficit Hyperactivity Disorder • CNS Disorders • Psychiatry
December 06, 2021
Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
(clinicaltrials.gov)
- P3; N=114; Completed; Sponsor: Orient Pharma Co., Ltd.; Active, not recruiting ➔ Completed
Clinical • Trial completion • ADHD (Impulsive Aggression) • Attention Deficit Hyperactivity Disorder • CNS Disorders • Psychiatry
1 to 2
Of
2
Go to page
1